Menu
Other Vial/Ampoule

General anesthetics (e.g., Propofol, Sevoflurane, Fentanyl)

Standard
Active Ingredient
-
Estimated Price
Not specified

Monitor respiratory function. Risk apnea.

Author Profile Picture
Medically Reviewed By
Prof. Dr. Mohamed Hutaif
Consultant Orthopedic Surgeon
Medical Disclaimer The information provided in this comprehensive guide is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with your physician before taking any new medication.

Comprehensive Clinical Guide: General Anesthetics

1. Introduction and Overview

General anesthesia represents a state of controlled, reversible unconsciousness characterized by analgesia, amnesia, loss of consciousness, inhibition of sensory and autonomic reflexes, and skeletal muscle relaxation. Unlike sedation, general anesthesia requires the involvement of a specialized anesthesia provider (Anesthesiologist or CRNA) to monitor vital functions, as the patient’s ability to maintain independent airway patency and hemodynamic stability is compromised.

The pharmacological agents employed—Propofol, Sevoflurane, and Fentanyl—function as cornerstones of modern surgical practice. By manipulating neurotransmitter pathways, these agents allow for complex surgical interventions while ensuring patient safety and comfort. This guide serves as a clinical reference for the pharmacological profile, administration protocols, and safety considerations of these essential medications.


2. Deep-Dive: Mechanisms of Action and Pharmacokinetics

The efficacy of general anesthetics relies on their ability to modulate synaptic transmission within the Central Nervous System (CNS).

Pharmacological Profiles

Agent Class Primary Mechanism Primary Pharmacokinetics
Propofol Alkylphenol GABA-A receptor agonist Rapid onset (30s), short duration due to redistribution.
Sevoflurane Halogenated Ether GABA-A/Glycine receptor modulation Rapid uptake/elimination via alveolar gas exchange.
Fentanyl Synthetic Opioid Mu-opioid receptor agonist Highly lipophilic, rapid crossing of blood-brain barrier.

Mechanism of Action Details

  • Propofol: Increases the duration of GABA-activated chloride channel opening. It hyperpolarizes the postsynaptic neuronal membrane, leading to decreased excitability. It is unique for its antiemetic properties and rapid metabolic clearance.
  • Sevoflurane: Acts on multiple ligand-gated ion channels. It enhances inhibitory synaptic activity (GABA-A) and inhibits excitatory synaptic activity (NMDA, nicotinic acetylcholine receptors). Its low blood-gas partition coefficient allows for rapid induction and emergence.
  • Fentanyl: Acts primarily on mu-opioid receptors in the CNS and periphery. It inhibits the release of excitatory neurotransmitters (substance P) and decreases the firing rate of nociceptive neurons, providing profound analgesia.

3. Clinical Indications and Usage

Indications for Use

  • Propofol: Induction and maintenance of general anesthesia; sedation for mechanically ventilated adult patients in the ICU; Monitored Anesthesia Care (MAC) for diagnostic procedures.
  • Sevoflurane: Induction and maintenance of general anesthesia in pediatric and adult patients. It is the preferred inhalational agent for mask induction due to its non-pungent odor.
  • Fentanyl: Adjunct to general and regional anesthesia; management of perioperative pain; sedation for short-duration procedures (often in combination with benzodiazepines).

Dosage Guidelines (General)

  • Propofol:
    • Induction (Healthy Adult): 1.5–2.5 mg/kg IV.
    • Maintenance: 100–200 mcg/kg/min infusion.
  • Sevoflurane:
    • Induction: 0.5%–8% (titrated to effect).
    • Maintenance: 0.5%–3% (titrated to MAC—Minimum Alveolar Concentration).
  • Fentanyl:
    • Analgesic Adjunct: 1–2 mcg/kg IV.
    • High-dose Anesthesia: 5–50 mcg/kg IV (for cardiac surgery).

4. Risks, Side Effects, and Contraindications

Contraindications

  • Propofol: Known hypersensitivity to egg, soy, or soybean oil; pregnancy (unless necessary); patients with severe lipid metabolism disorders.
  • Sevoflurane: Known history of malignant hyperthermia; severe hepatic/renal impairment (use with caution).
  • Fentanyl: Severe respiratory depression; acute bronchial asthma; concurrent use of MAO inhibitors (within 14 days).

Adverse Effects

  • Respiratory: Propofol and Fentanyl induce dose-dependent respiratory depression and apnea.
  • Hemodynamic: Propofol causes significant dose-dependent hypotension and myocardial depression.
  • Neurological: Sevoflurane may cause emergence agitation, particularly in pediatric populations.
  • Rare/Severe: Propofol Infusion Syndrome (PRIS)—characterized by metabolic acidosis, rhabdomyolysis, and cardiac failure—is a lethal complication of prolonged, high-dose infusions.

5. Pregnancy, Lactation, and Drug Interactions

Pregnancy and Lactation

  • Propofol: Category B. Crosses the placenta but is rapidly cleared by the fetus. Used frequently for C-sections at induction doses.
  • Sevoflurane: Category B. May cause uterine relaxation, potentially increasing blood loss during obstetric procedures.
  • Fentanyl: Category C. Rapid placental transfer; can cause neonatal respiratory depression if administered close to delivery.

Critical Drug Interactions

  • CNS Depressants: Benzodiazepines, alcohol, and barbiturates exhibit synergistic effects with Propofol and Fentanyl, significantly increasing the risk of respiratory arrest.
  • Neuromuscular Blockers: Potentiated by Sevoflurane; dosage adjustments for Rocuronium or Vecuronium are required.
  • MAO Inhibitors: Severe, potentially fatal hypertensive or hypotensive reactions can occur with Fentanyl.

6. Overdose Management

Management of anesthetic overdose is centered on airway protection and hemodynamic support.

  1. Airway/Breathing: Immediate cessation of the offending agent. Secure the airway via endotracheal intubation or bag-valve-mask ventilation with 100% oxygen.
  2. Circulation: Hypotension should be treated with fluid boluses and vasopressors (e.g., Phenylephrine, Ephedrine).
  3. Pharmacological Reversal:
    • Fentanyl: Administer Naloxone (0.4 mg IV, titrated to effect). Note the short half-life of Naloxone compared to Fentanyl; repeat dosing may be required.
    • Propofol/Sevoflurane: No direct reversal agent exists. Management is purely supportive (waiting for redistribution/elimination).

7. Frequently Asked Questions (FAQ)

1. Why is Propofol often associated with "Propofol Infusion Syndrome"?

PRIS is a rare but fatal complication of high-dose, long-term infusion (usually >48 hours). It interferes with mitochondrial fatty acid metabolism. It is generally not a risk in standard surgical induction.

2. Is Sevoflurane safe for patients with a history of Malignant Hyperthermia?

No. Sevoflurane is a volatile anesthetic and a known trigger for malignant hyperthermia in susceptible individuals. Total Intravenous Anesthesia (TIVA) using Propofol is the required alternative.

3. How does Fentanyl affect blood pressure?

Fentanyl is generally hemodynamically stable, but it can induce bradycardia due to increased vagal tone. It does not cause the direct myocardial depression seen with Propofol.

4. Can general anesthetics be used in patients with liver disease?

Yes, but dosages must be adjusted. Propofol is primarily metabolized in the liver, while Sevoflurane is primarily eliminated via exhalation. Fentanyl metabolism is significantly slowed in hepatic failure.

5. Why is Propofol milky in appearance?

Propofol is formulated in a lipid emulsion (soybean oil, glycerol, and egg lecithin) because the drug itself is highly lipophilic and insoluble in water.

6. What is the difference between MAC and General Anesthesia?

MAC (Monitored Anesthesia Care) involves sedation where the patient maintains their own airway. General anesthesia involves a controlled, total loss of consciousness and often requires an artificial airway (ET tube or LMA).

7. How long does it take for Sevoflurane to leave the body?

Because it is poorly soluble in blood, Sevoflurane is rapidly exhaled. Recovery is usually rapid, typically within 5–15 minutes after cessation of the gas.

8. Are these medications addictive?

Propofol and Fentanyl have high potential for abuse. Fentanyl, being an opioid, carries a significant risk of physical dependence and addiction. Propofol is increasingly recognized for its abuse potential among healthcare workers.

9. What should I do if a patient has an allergic reaction to Propofol?

If an anaphylactoid reaction occurs, stop the infusion immediately. Administer epinephrine, antihistamines, and corticosteroids, and provide aggressive fluid resuscitation. If the reaction is due to the egg lecithin, avoid all further Propofol.

10. Can I drive after general anesthesia?

No. Patients are legally and medically restricted from driving for at least 24 hours following general anesthesia, as residual cognitive and motor impairment persists long after the patient appears "awake."


8. Clinical Conclusion

The safe administration of general anesthetics requires a precise understanding of pharmacodynamics and the individual patient’s physiological reserves. While Propofol, Sevoflurane, and Fentanyl are remarkably effective, their narrow therapeutic window necessitates rigorous monitoring of airway, breathing, and circulation. Clinicians must remain vigilant for idiosyncratic reactions and cumulative toxicity, ensuring that every patient receives a tailored anesthetic plan that prioritizes safety and rapid, stable emergence.

Disclaimer: This guide is intended for educational and professional reference only. Always adhere to your facility’s specific protocols and current clinical guidelines.

Related Medical Information

Share this guide: